We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.

We are a clinical-stage biotechnology company listed on NASDAQ First North Growth Market Sweden with a resolute vision of the future:

Developing innovative vaccines for a healthier world

Two mature forensic scientists working together on a new research in a laboratory.
S1080979

Advancing groundbreaking vaccines through our exclusive technological platform

By leveraging our proprietary ExpreS2 protein expression system, we are playing a key role in the development of cutting-edge vaccines to address some of the worst and most impactful diseases.

Our vaccine candidates aim at bringing hope to millions by preventing infectious diseases and treating cancer, saving lives, and fostering resilient communities.

Latest news

Notice to attend the Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (publ)

N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the versions, the Swedish version shall prevail. The shareholders of ExpreS2ion Biotech Holding AB (publ), reg. no. 559033-3729 (the "Company"), are hereby given notice to attend the Extraordinary General Meeting to be held on 21…

Read more

ExpreS2ion to present in upcoming investor events

Hørsholm, Denmark, 10 September 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor events, including Investing in Life Science: From Seed to Success and a Danish Stock seminar for institutional investors.

Read more

ExpreS2ion announces publication of sponsored research reports

Hørsholm, Denmark, 23 August 2024 – ExpreS2ion Biotech Holding AB (Nasdaq First North Growth Market: EXPRS2) is pleased to announce the publication of two new research reports by sponsored analysts, which delve into the fundamentals of the company’s innovative pipeline and proprietary ExpreS2 platform.

Read more